Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity-Reference-Cited by-同舟云学术

Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity

Published:2015-10-26 Issue:1 Volume:268 Page:311-327
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

van Egmond Marjolein¹²,Vidarsson Gestur³,Bakema Jantine E.⁴

Affiliation:

1. Department of Molecular Cell Biology and Immunology; VU University Medical Center; Amsterdam The Netherlands

2. Department of Surgery; VU University Medical Center; Amsterdam The Netherlands

3. Department of Experimental Immunohematology; Sanquin Research and Landsteiner Laboratory; Academic Medical Center; University of Amsterdam; Amsterdam The Netherlands

4. Tumor Biology Section; Department of Otolaryngology/Head-Neck Surgery; VU University Medical Center; Amsterdam The Netherlands

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imr.12333/fullpdf

Reference107 articles.

1. Control of adaptive immunity by the innate immune system;Iwasaki;Nat Immunol,2015

2. Innate immune recognition;Janeway;Annu Rev Immunol,2002

3. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors;Kawai;Nat Immunol,2010

4. Pattern recognition receptors and inflammation;Takeuchi;Cell,2010

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tethering of soluble immune effectors to mucin and chitin reflects a convergent and dynamic role in gut immunity;Philosophical Transactions of the Royal Society B: Biological Sciences;2024-03-18

2. Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective;Experimental & Molecular Medicine;2024-03-06

3. Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy;Journal of Pharmaceutical Investigation;2023-12-01

4. Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19;Life Science Alliance;2023-09-12

5. Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19;2022-12-21